CD8A and neoplasm: Furthermore, multiplex IHC revealed the distinct co-localisation patterns of ICAM-1 with CD31, CD8, and CD103 in PAK1KO and PAK4KO tumours, indicating enhanced vascular activation and increased activation of immune cells, such as cytotoxic CD8+ T-cells and CD103+ dendritic cells.